Literature DB >> 17923519

PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.

Jie Li1, David T Glover, Alexander J Szalai, Susan K Hollingshead, David E Briles.   

Abstract

Pneumococcal surface protein A (PspA) and PspC are important virulence factors. Their absence has been shown to allow improved clearance of pneumococci from the blood of mice and to decrease pneumococcal virulence. In the presence of antibody and complement, pneumococci attach to erythrocytes in a process called immune adherence (IA), which facilitates their delivery to, and eventual phagocytosis by, macrophages. It is not known, however, if PspA and PspC affect IA. Using PspA and/or PspC isogenic mutants and complement-deficient mouse sera, we demonstrated that absence of PspA allows greater deposition of C1q and thus increased classical-pathway-mediated C3 deposition. In the absence of both PspA and PspC, there is also a major increase in C1q-independent C3 deposition through the alternative pathway. The latter was observed even though absence of PspC alone did not have a major effect on alternative-pathway-dependent complement deposition. The enhanced complement C3 deposition realized in the absence of PspA alone and in the absence of PspA and PspC resulted in both greatly increased IA to human erythrocytes and improved transfer of pneumococci from erythrocytes to phagocytes. These data provide new insight into how PspA and PspC act in synergy to protect pneumococci from complement-dependent clearance during invasive infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923519      PMCID: PMC2168335          DOI: 10.1128/IAI.00839-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

Authors:  R A NELSON
Journal:  Science       Date:  1953-12-18       Impact factor: 47.728

2.  Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.

Authors:  C Neeleman; S P Geelen; P C Aerts; M R Daha; T E Mollnes; J J Roord; G Posthuma; H van Dijk; A Fleer
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Primate erythrocyte-immune complex-clearing mechanism.

Authors:  J B Cornacoff; L A Hebert; W L Smead; M E VanAman; D J Birmingham; F J Waxman
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

4.  Characterization of binding of human lactoferrin to pneumococcal surface protein A.

Authors:  A Håkansson; H Roche; S Mirza; L S McDaniel; A Brooks-Walter; D E Briles
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  PspC, a pneumococcal surface protein, binds human factor H.

Authors:  S Dave; A Brooks-Walter; M K Pangburn; L S McDaniel
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.

Authors:  Priya Balachandran; Alexis Brooks-Walter; Anni Virolainen-Julkunen; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.

Authors:  S W Tas; L B Klickstein; S F Barbashov; A Nicholson-Weller
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

8.  Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia.

Authors:  Jose Yuste; Marina Botto; James C Paton; David W Holden; Jeremy S Brown
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

9.  Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.

Authors:  W Emlen; G Burdick; V Carl; P J Lachmann
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

10.  Complement receptor 1/CD35 is a receptor for mannan-binding lectin.

Authors:  I Ghiran; S F Barbashov; L B Klickstein; S W Tas; J C Jensenius; A Nicholson-Weller
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  37 in total

1.  Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.

Authors:  Kevin Fabrizio; Catherine Manix; Allan J Guimaraes; Joshua D Nosanchuk; Liise-Anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

2.  The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.

Authors:  Jose Yuste; Suneeta Khandavilli; Naadir Ansari; Kairya Muttardi; Laura Ismail; C Hyams; Jeffrey Weiser; Timothy Mitchell; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

Review 3.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.

Authors:  Jie Li; Jennifer P Wang; Ionita Ghiran; Anna Cerny; Alexander J Szalai; David E Briles; Robert W Finberg
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

Review 5.  Procession to pediatric bacteremia and sepsis: covert operations and failures in diplomacy.

Authors:  Stacey L Bateman; Patrick C Seed
Journal:  Pediatrics       Date:  2010-06-21       Impact factor: 7.124

6.  CovR Regulates Streptococcus mutans Susceptibility To Complement Immunity and Survival in Blood.

Authors:  Lívia A Alves; Ryota Nomura; Flávia S Mariano; Erika N Harth-Chu; Rafael N Stipp; Kazuhiko Nakano; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

7.  A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).

Authors:  Kristopher R Genschmer; Mary Ann Accavitti-Loper; David E Briles
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

8.  Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.

Authors:  Adriana T Moreno; Maria Leonor S Oliveira; Daniela M Ferreira; Paulo L Ho; Michelle Darrieux; Luciana C C Leite; Jorge M C Ferreira; Fabiana C Pimenta; Ana Lúcia S S Andrade; Eliane N Miyaji
Journal:  Clin Vaccine Immunol       Date:  2010-01-20

9.  Haematophagic Caenorhabditis elegans.

Authors:  Veeren M Chauhan; David I Pritchard
Journal:  Parasitology       Date:  2018-10-25       Impact factor: 3.234

10.  Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B.

Authors:  Merit Melin; Hanna Jarva; Lotta Siira; Seppo Meri; Helena Käyhty; Merja Väkeväinen
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.